Zelira Therapeutics's market cap is currently ―. The company's EPS TTM is AU$-3.219; its P/E ratio is -0.22; Zelira Therapeutics is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 2.75M	AU$ 4.97M	AU$ 1.70M	AU$ 3.07M	AU$ 5.69M
Total Assets	AU$ 37.70M	AU$ 39.37M	AU$ 35.79M	AU$ 3.52M	AU$ 6.31M
Total Debt	AU$ 500.91K	AU$ 551.08K	AU$ 632.32K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -2.25M	AU$ -4.42M	AU$ -1.06M	AU$ -3.07M	AU$ -5.69M
Total Liabilities	AU$ 2.01M	AU$ 1.54M	AU$ 1.24M	AU$ 407.24K	AU$ 99.42K
Stockholders Equity	AU$ 35.20M	AU$ 37.83M	AU$ 34.55M	AU$ 3.11M	AU$ 6.21M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Zelira Therapeutics Earnings and Revenue History

Income Statement >

Zelira Therapeutics Debt to Assets

Balance Sheet >

Zelira Therapeutics Cash Flow

Cash Flow >

Zelira Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing